Last reviewed: May 30, 2026

Last updated: May 30, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell, essential for energy metabolism, DNA repair, and cellular signaling. NAD+ levels naturally decline with age—declining approximately 50% between ages 20 and 50—making it a relevant biomarker in longevity and metabolic health discussions.

For individuals exploring precision wellness, understanding NAD+ function alongside genetic predispositions and other biomarkers provides broader context for health decisions. PlexusDx supports this approach by integrating genetic insights with clinical understanding, enabling more informed conversations with healthcare providers about personalized metabolic strategies.

The Biochemical Role of NAD+ in Cellular Function

NAD+ functions as a coenzyme in two primary forms: NAD+ (oxidized) and NADH (reduced). These forms shuttle electrons in cellular processes, particularly in glycolysis, the citric acid cycle, and the electron transport chain—the core mechanisms of ATP (energy) production. Approximately 90% of cellular energy relies on NAD+-dependent pathways.

Beyond energy production, NAD+ activates sirtuins, proteins linked to cellular repair, inflammation regulation, and longevity pathways. It also supports NAD+-dependent enzymes like PARPs (poly-ADP-ribose polymerases) involved in DNA damage response and genomic stability. These mechanisms explain why NAD+ is considered relevant to healthy aging discussions.

NAD+ Metabolism Pathways and Biomarker Measurement Context

NAD+ is synthesized via two primary pathways: the de novo pathway (from the amino acid tryptophan) and the salvage pathway (recycling nicotinamide). Age, diet, exercise, and certain genetic polymorphisms influence NAD+ synthesis efficiency and cellular availability. Measuring NAD+ levels requires specialized testing and should be interpreted within a comprehensive biomarker panel and clinical context.

NAD+ Context Factor Clinical Relevance
Age-related decline NAD+ drops ~50% from age 20 to 50, affecting mitochondrial function
Salvage pathway efficiency Genetic variants influence NAD+ recycling from nicotinamide precursors
Mitochondrial capacity NAD+ availability correlates with metabolic flexibility and exercise response
Sirtuin activation NAD+ supports SIRT1-7 activity, linked to stress resistance and cellular repair
Dietary sources Tryptophan, nicotinamide, and nicotinic acid intake modulates NAD+ synthesis

Age-Related NAD+ Decline and Metabolic Health Implications

NAD+ depletion correlates with reduced mitochondrial function, impaired glucose metabolism, diminished exercise capacity, and increased inflammation. Aging, chronic stress, sleep disruption, and sedentary lifestyle accelerate NAD+ decline. Some research suggests NAD+ supplementation may support metabolic health in older populations, though human clinical evidence remains limited.

NAD+ precursors like NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are available supplementally, intended to replenish cellular NAD+. However, bioavailability, dosing, and individual response variability remain areas of ongoing research. Healthcare provider guidance is essential before starting supplementation, especially for individuals on medications affecting metabolism.

NAD+ Assessment, Personalization, and Provider-Guided Decision-Making

Measuring NAD+ requires specialized blood or tissue testing not routinely available in standard clinical labs. Some specialized biomarker panels include NAD+ or NAD+/NADH ratios, but interpretation must account for circadian rhythms, stress, exercise timing, and overall metabolic context. Single measurements lack clinical standardization and should not drive treatment decisions independently.

A comprehensive approach considers NAD+ alongside other metabolic biomarkers—fasting glucose, insulin, mitochondrial markers, inflammatory indicators, and genetic predispositions in metabolic pathways. Qualified providers can evaluate NAD+ status within this broader framework, assess lifestyle factors (sleep, exercise, diet), and recommend evidence-informed interventions tailored to individual circumstances.

How PlexusDx Supports a More Personalized Approach

While PlexusDx specializes in compounded GLP-1 medications and metabolic support, we recognize that NAD+ and biomarker context inform broader precision wellness conversations. PlexusDx's Precision Peptide Genetic Test reveals predispositions in metabolic pathways including GLP1R, GIPR, FTO, and MC4R variants—factors that can support a more informed discussion about personalized metabolic health strategies alongside clinical assessment of NAD+ and other biomarkers.

The Precision Peptide Genetic Test identifies genetic predispositions in peptide and metabolic signaling pathways, not pharmacogenetic responses. These insights may help provide context for how your body handles metabolic processes, glucose regulation, and energy utilization. However, genetic predispositions do not predict exact NAD+ levels, NAD+ supplementation response, or medication outcomes. Interpretation requires a qualified healthcare provider.

Understanding your genetic predispositions in metabolic pathways—revealed through PlexusDx's genetic test—can support a more informed conversation with your provider about comprehensive wellness strategies, including whether NAD+ assessment and supplementation align with your health goals and medical history.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $179-$229/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the difference between NAD+ and NADH?

NAD+ (oxidized form) and NADH (reduced form) are the two states of the same coenzyme. NAD+ accepts electrons in metabolic reactions, becoming NADH; NADH donates those electrons for ATP production. Both forms are essential for energy metabolism and cellular function.

Can NAD+ supplementation improve energy and metabolism?

Limited human clinical evidence supports NAD+ precursor supplementation (NMN, NR) for energy or metabolic improvement. Some animal and small human studies suggest potential benefits, but results remain inconsistent. A qualified provider should evaluate whether supplementation is appropriate for your individual circumstances.

How does NAD+ relate to GLP-1 and metabolic wellness?

NAD+ supports mitochondrial function and energy metabolism, foundational processes that complement GLP-1 medications' metabolic effects.

What are the safety considerations for NAD+ supplementation?

NAD+ precursors (NMN, NR) are generally well-tolerated at recommended doses, but long-term safety data in humans remains limited. Potential interactions with medications affecting metabolism are possible. Always consult a qualified provider before starting supplementation, especially if you have kidney disease, liver disease, or take medications.

Does the PlexusDx Precision Peptide Genetic Test measure NAD+ metabolism?

The Precision Peptide Genetic Test reveals predispositions in metabolic pathways (GLP1R, GIPR, FTO, MC4R variants) relevant to glucose and energy regulation. While it does not directly measure NAD+ or NAD+-specific genetics, it provides context for understanding your metabolic predispositions, which should be interpreted with a provider.

Related Reading

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves